FDA recall F-0070-2020

Product

OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ

Reason for recall

Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).

Distribution

Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.

Key facts

Status

Terminated

Initiation date

2019-09-25

Report date

2019-10-30

Termination date

2020-02-20

Voluntary/Mandated

Voluntary: Firm initiated

Location

Southlake, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=F-0070-2020